Verve Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Verve Therapeutics, Inc. has filed 344 SEC EDGAR filings since 22 Jan 2021

SEC filing history

Showing 251-275 of 344 matching filings.

Per page
25
Current page
11
4

PRIMARY DOCUMENT

Filing date
11 Feb 2022
Reporting date
09 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92605

ARCH VENTURE FUND X, L.P. - VERVE THERAPEUTICS, INC. -- SCH 13G

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92605

SC 13G/A filing

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92605

SEC SCHEDULE 13G

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92605

SEC SCHEDULE 13G

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Jan 2022
Reporting date
26 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92605

SC 13G filing

Filing date
24 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2022
Reporting date
04 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Dec 2021
Reporting date
27 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
28 Dec 2021
Reporting date
23 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92605

13G/A

Filing date
28 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Dec 2021
Reporting date
22 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Dec 2021
Reporting date
22 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Dec 2021
Reporting date
16 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Dec 2021
Reporting date
02 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Dec 2021
Reporting date
02 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Nov 2021
Reporting date
29 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
30 Nov 2021
Reporting date
29 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40489

10-Q

Filing date
12 Aug 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .